nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ALDH1A3—stomach cancer	0.0788	0.219	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—PPAP2A—stomach cancer	0.0522	0.145	CbGpPWpGaD
Icosapent ethyl—DGAT1—hematopoietic system—stomach cancer	0.0329	0.261	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RBP1—stomach cancer	0.0327	0.0911	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RXRB—stomach cancer	0.0238	0.0662	CbGpPWpGaD
Icosapent ethyl—DGAT1—digestive system—stomach cancer	0.0229	0.182	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—stomach cancer	0.0211	0.168	CbGeAlD
Icosapent ethyl—DGAT1—endocrine gland—stomach cancer	0.0189	0.15	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RARB—stomach cancer	0.0172	0.0479	CbGpPWpGaD
Icosapent ethyl—DGAT1—liver—stomach cancer	0.0171	0.135	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RBP4—stomach cancer	0.0167	0.0467	CbGpPWpGaD
Icosapent ethyl—DGAT1—lymph node—stomach cancer	0.0131	0.104	CbGeAlD
Icosapent ethyl—Icosapent—FADS1—stomach cancer	0.0112	0.412	CrCbGaD
Icosapent ethyl—Alpha-Linolenic Acid—FADS1—stomach cancer	0.0109	0.402	CrCbGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA1—stomach cancer	0.0103	0.0288	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—stomach cancer	0.00872	0.0243	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ECHS1—stomach cancer	0.00703	0.0196	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—stomach cancer	0.00661	0.0184	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF2—stomach cancer	0.00619	0.0172	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—RORA—stomach cancer	0.00611	0.017	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.00414	0.0115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—MAPK1—stomach cancer	0.00371	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.00347	0.00967	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACAD8—stomach cancer	0.00286	0.00798	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.0028	0.0078	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.00263	0.00733	CbGpPWpGaD
Icosapent ethyl—Icosapent—PPARG—stomach cancer	0.00257	0.0948	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—GMPR2—stomach cancer	0.00255	0.00711	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.00246	0.00686	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.00244	0.00678	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—stomach cancer	0.0024	0.00669	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—IDH3B—stomach cancer	0.00233	0.0065	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SUCLG1—stomach cancer	0.00233	0.0065	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NDUFV1—stomach cancer	0.00217	0.00605	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NDUFS1—stomach cancer	0.00217	0.00605	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.00212	0.00591	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—stomach cancer	0.00212	0.00589	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PGLS—stomach cancer	0.00193	0.00539	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BLVRB—stomach cancer	0.00193	0.00539	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPAP2A—stomach cancer	0.00185	0.00514	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.00177	0.00494	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NDUFA2—stomach cancer	0.00164	0.00458	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CKB—stomach cancer	0.00164	0.00458	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA1—stomach cancer	0.00164	0.00458	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FBP1—stomach cancer	0.00164	0.00458	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLIN2—stomach cancer	0.00155	0.00431	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA2—stomach cancer	0.0015	0.00419	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NT5E—stomach cancer	0.00147	0.00408	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PGAM1—stomach cancer	0.00147	0.00408	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLCE1—stomach cancer	0.0014	0.0039	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALDH7A1—stomach cancer	0.0014	0.0039	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—stomach cancer	0.00138	0.051	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—UMPS—stomach cancer	0.00134	0.00374	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—stomach cancer	0.00127	0.00353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PDHA1—stomach cancer	0.00125	0.00347	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ECHS1—stomach cancer	0.00125	0.00347	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TYMP—stomach cancer	0.00117	0.00326	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FADS1—stomach cancer	0.00117	0.00326	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SREBF2—stomach cancer	0.0011	0.00306	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—RORA—stomach cancer	0.00108	0.00302	CbGpPWpGaD
Icosapent ethyl—Icosapent—PTGS2—stomach cancer	0.00108	0.04	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—ALDOB—stomach cancer	0.00102	0.00283	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000958	0.00267	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000956	0.00266	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX5—stomach cancer	0.000945	0.00263	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DPYD—stomach cancer	0.000929	0.00259	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000842	0.00235	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—stomach cancer	0.000822	0.00229	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2A6—stomach cancer	0.000812	0.00226	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AKR1C3—stomach cancer	0.00079	0.0022	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ENO1—stomach cancer	0.00077	0.00215	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000757	0.00211	CbGpPWpGaD
Icosapent ethyl—Chills—Capecitabine—stomach cancer	0.00072	0.00148	CcSEcCtD
Icosapent ethyl—Dyspepsia—Fluorouracil—stomach cancer	0.000718	0.00147	CcSEcCtD
Icosapent ethyl—Arrhythmia—Capecitabine—stomach cancer	0.000717	0.00147	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—stomach cancer	0.000715	0.00147	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000713	0.00146	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—stomach cancer	0.000711	0.00146	CcSEcCtD
Icosapent ethyl—Decreased appetite—Fluorouracil—stomach cancer	0.000709	0.00145	CcSEcCtD
Icosapent ethyl—Alopecia—Capecitabine—stomach cancer	0.000709	0.00145	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—stomach cancer	0.000709	0.00145	CcSEcCtD
Icosapent ethyl—Dysgeusia—Docetaxel—stomach cancer	0.000707	0.00145	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000705	0.00144	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—stomach cancer	0.000703	0.00144	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Irinotecan—stomach cancer	0.000702	0.00144	CcSEcCtD
Icosapent ethyl—Malnutrition—Capecitabine—stomach cancer	0.000699	0.00143	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—stomach cancer	0.000699	0.00143	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—stomach cancer	0.000699	0.00143	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—stomach cancer	0.000699	0.00143	CcSEcCtD
Icosapent ethyl—Back pain—Docetaxel—stomach cancer	0.000698	0.00143	CcSEcCtD
Icosapent ethyl—Pain—Fluorouracil—stomach cancer	0.000698	0.00143	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—stomach cancer	0.000688	0.00141	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—stomach cancer	0.000685	0.0014	CcSEcCtD
Icosapent ethyl—Dysgeusia—Capecitabine—stomach cancer	0.000684	0.0014	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CD44—stomach cancer	0.000683	0.0019	CbGpPWpGaD
Icosapent ethyl—Angina pectoris—Epirubicin—stomach cancer	0.000681	0.00139	CcSEcCtD
Icosapent ethyl—Back pain—Capecitabine—stomach cancer	0.000676	0.00139	CcSEcCtD
Icosapent ethyl—Body temperature increased—Irinotecan—stomach cancer	0.000674	0.00138	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000674	0.00138	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Fluorouracil—stomach cancer	0.000673	0.00138	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—stomach cancer	0.000672	0.00138	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—stomach cancer	0.00067	0.00137	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—stomach cancer	0.000666	0.00136	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—stomach cancer	0.000666	0.00136	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000663	0.00185	CbGpPWpGaD
Icosapent ethyl—Gastritis—Doxorubicin—stomach cancer	0.000662	0.00136	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.00066	0.00135	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—stomach cancer	0.000651	0.00133	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Capecitabine—stomach cancer	0.000648	0.00133	CcSEcCtD
Icosapent ethyl—Syncope—Docetaxel—stomach cancer	0.000647	0.00133	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—stomach cancer	0.000646	0.00132	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—stomach cancer	0.000646	0.00132	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—stomach cancer	0.000646	0.00132	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—stomach cancer	0.000645	0.00132	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—stomach cancer	0.000638	0.00131	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Docetaxel—stomach cancer	0.000634	0.0013	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—stomach cancer	0.000634	0.0013	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—stomach cancer	0.00063	0.00129	CcSEcCtD
Icosapent ethyl—Malaise—Capecitabine—stomach cancer	0.00063	0.00129	CcSEcCtD
Icosapent ethyl—Cough—Docetaxel—stomach cancer	0.00063	0.00129	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—stomach cancer	0.00063	0.00129	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—stomach cancer	0.000628	0.00129	CcSEcCtD
Icosapent ethyl—Vertigo—Capecitabine—stomach cancer	0.000628	0.00129	CcSEcCtD
Icosapent ethyl—Syncope—Capecitabine—stomach cancer	0.000627	0.00128	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—stomach cancer	0.000627	0.00128	CcSEcCtD
Icosapent ethyl—Hypertension—Docetaxel—stomach cancer	0.000623	0.00128	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—stomach cancer	0.000623	0.00128	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—stomach cancer	0.000623	0.00128	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—stomach cancer	0.000622	0.00127	CcSEcCtD
Icosapent ethyl—Myalgia—Docetaxel—stomach cancer	0.000614	0.00126	CcSEcCtD
Icosapent ethyl—Chest pain—Docetaxel—stomach cancer	0.000614	0.00126	CcSEcCtD
Icosapent ethyl—Arthralgia—Docetaxel—stomach cancer	0.000614	0.00126	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Capecitabine—stomach cancer	0.000614	0.00126	CcSEcCtD
Icosapent ethyl—Asthenia—Irinotecan—stomach cancer	0.000611	0.00125	CcSEcCtD
Icosapent ethyl—Cough—Capecitabine—stomach cancer	0.00061	0.00125	CcSEcCtD
Icosapent ethyl—Hypertension—Capecitabine—stomach cancer	0.000603	0.00124	CcSEcCtD
Icosapent ethyl—Dry mouth—Docetaxel—stomach cancer	0.000601	0.00123	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—stomach cancer	0.000597	0.00122	CcSEcCtD
Icosapent ethyl—Chest pain—Capecitabine—stomach cancer	0.000595	0.00122	CcSEcCtD
Icosapent ethyl—Myalgia—Capecitabine—stomach cancer	0.000595	0.00122	CcSEcCtD
Icosapent ethyl—Arthralgia—Capecitabine—stomach cancer	0.000595	0.00122	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—stomach cancer	0.000593	0.00122	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Docetaxel—stomach cancer	0.000589	0.00121	CcSEcCtD
Icosapent ethyl—Oedema—Docetaxel—stomach cancer	0.000589	0.00121	CcSEcCtD
Icosapent ethyl—Discomfort—Capecitabine—stomach cancer	0.000588	0.0012	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—stomach cancer	0.000588	0.0012	CcSEcCtD
Icosapent ethyl—Infection—Docetaxel—stomach cancer	0.000585	0.0012	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—stomach cancer	0.000584	0.0012	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—stomach cancer	0.000583	0.0012	CcSEcCtD
Icosapent ethyl—Dry mouth—Capecitabine—stomach cancer	0.000582	0.00119	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PPP2R1A—stomach cancer	0.000581	0.00162	CbGpPWpGaD
Icosapent ethyl—Pneumonia—Doxorubicin—stomach cancer	0.00058	0.00119	CcSEcCtD
Icosapent ethyl—Shock—Docetaxel—stomach cancer	0.00058	0.00119	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—stomach cancer	0.000577	0.00118	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—stomach cancer	0.000576	0.00118	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—stomach cancer	0.000576	0.00118	CcSEcCtD
Icosapent ethyl—Tachycardia—Docetaxel—stomach cancer	0.000575	0.00118	CcSEcCtD
Icosapent ethyl—Oedema—Capecitabine—stomach cancer	0.00057	0.00117	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—stomach cancer	0.00057	0.00159	CbGpPWpGaD
Icosapent ethyl—Infection—Capecitabine—stomach cancer	0.000567	0.00116	CcSEcCtD
Icosapent ethyl—Dizziness—Irinotecan—stomach cancer	0.000563	0.00115	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—HMOX1—stomach cancer	0.000562	0.00157	CbGpPWpGaD
Icosapent ethyl—Anorexia—Docetaxel—stomach cancer	0.000561	0.00115	CcSEcCtD
Icosapent ethyl—Shock—Capecitabine—stomach cancer	0.000561	0.00115	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—stomach cancer	0.000561	0.00115	CcSEcCtD
Icosapent ethyl—Tachycardia—Capecitabine—stomach cancer	0.000557	0.00114	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—stomach cancer	0.000555	0.00114	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—stomach cancer	0.000553	0.00113	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Capecitabine—stomach cancer	0.000551	0.00113	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—stomach cancer	0.000544	0.00111	CcSEcCtD
Icosapent ethyl—Anorexia—Capecitabine—stomach cancer	0.000544	0.00111	CcSEcCtD
Icosapent ethyl—Vomiting—Irinotecan—stomach cancer	0.000542	0.00111	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—stomach cancer	0.000541	0.00111	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—stomach cancer	0.00054	0.00111	CcSEcCtD
Icosapent ethyl—Rash—Irinotecan—stomach cancer	0.000537	0.0011	CcSEcCtD
Icosapent ethyl—Dermatitis—Irinotecan—stomach cancer	0.000537	0.0011	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000537	0.0011	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—stomach cancer	0.000536	0.0011	CcSEcCtD
Icosapent ethyl—Insomnia—Docetaxel—stomach cancer	0.000533	0.00109	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—TYMS—stomach cancer	0.00053	0.00148	CbGpPWpGaD
Icosapent ethyl—Alopecia—Methotrexate—stomach cancer	0.000528	0.00108	CcSEcCtD
Icosapent ethyl—Dyspnoea—Docetaxel—stomach cancer	0.000525	0.00108	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—stomach cancer	0.000523	0.00146	CbGpPWpGaD
Icosapent ethyl—Malnutrition—Methotrexate—stomach cancer	0.00052	0.00107	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00052	0.00106	CcSEcCtD
Icosapent ethyl—Vomiting—Fluorouracil—stomach cancer	0.000519	0.00106	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—stomach cancer	0.000519	0.00106	CcSEcCtD
Icosapent ethyl—Dyspepsia—Docetaxel—stomach cancer	0.000519	0.00106	CcSEcCtD
Icosapent ethyl—Insomnia—Capecitabine—stomach cancer	0.000516	0.00106	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—stomach cancer	0.000515	0.00105	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—stomach cancer	0.000514	0.00105	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—stomach cancer	0.000514	0.00105	CcSEcCtD
Icosapent ethyl—Decreased appetite—Docetaxel—stomach cancer	0.000512	0.00105	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—stomach cancer	0.000509	0.00104	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000509	0.00104	CcSEcCtD
Icosapent ethyl—Dyspnoea—Capecitabine—stomach cancer	0.000508	0.00104	CcSEcCtD
Icosapent ethyl—Pain—Docetaxel—stomach cancer	0.000504	0.00103	CcSEcCtD
Icosapent ethyl—Constipation—Docetaxel—stomach cancer	0.000504	0.00103	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—stomach cancer	0.000503	0.00103	CcSEcCtD
Icosapent ethyl—Dyspepsia—Capecitabine—stomach cancer	0.000502	0.00103	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—stomach cancer	0.000502	0.00103	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—stomach cancer	0.0005	0.00102	CcSEcCtD
Icosapent ethyl—Decreased appetite—Capecitabine—stomach cancer	0.000496	0.00102	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—stomach cancer	0.000494	0.00101	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000492	0.00101	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ERCC2—stomach cancer	0.000492	0.00137	CbGpPWpGaD
Icosapent ethyl—Pain—Capecitabine—stomach cancer	0.000488	0.000999	CcSEcCtD
Icosapent ethyl—Constipation—Capecitabine—stomach cancer	0.000488	0.000999	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—stomach cancer	0.000487	0.000998	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Docetaxel—stomach cancer	0.000485	0.000995	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—stomach cancer	0.000483	0.000989	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—stomach cancer	0.000477	0.000977	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—stomach cancer	0.000471	0.000965	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Capecitabine—stomach cancer	0.00047	0.000963	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—stomach cancer	0.000469	0.000961	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—stomach cancer	0.000467	0.000958	CcSEcCtD
Icosapent ethyl—Body temperature increased—Docetaxel—stomach cancer	0.000466	0.000954	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—stomach cancer	0.000464	0.000952	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—stomach cancer	0.000463	0.00129	CbGpPWpGaD
Icosapent ethyl—Arrhythmia—Doxorubicin—stomach cancer	0.000462	0.000947	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—stomach cancer	0.000457	0.000937	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—stomach cancer	0.000454	0.00093	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—stomach cancer	0.000452	0.000926	CcSEcCtD
Icosapent ethyl—Body temperature increased—Capecitabine—stomach cancer	0.000451	0.000924	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—stomach cancer	0.00045	0.000923	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—stomach cancer	0.000443	0.000908	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—stomach cancer	0.000443	0.000908	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—stomach cancer	0.000443	0.000908	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—stomach cancer	0.000441	0.000904	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—stomach cancer	0.000439	0.0009	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—stomach cancer	0.000438	0.000897	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—stomach cancer	0.000437	0.000896	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—stomach cancer	0.000437	0.000895	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—stomach cancer	0.000436	0.000893	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—stomach cancer	0.000428	0.000877	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CAV1—stomach cancer	0.000427	0.00119	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA1—stomach cancer	0.000426	0.00119	CbGpPWpGaD
Icosapent ethyl—Cough—Epirubicin—stomach cancer	0.000425	0.000871	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—stomach cancer	0.000425	0.00087	CcSEcCtD
Icosapent ethyl—Asthenia—Docetaxel—stomach cancer	0.000423	0.000866	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—stomach cancer	0.000422	0.000864	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—stomach cancer	0.00042	0.000861	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—stomach cancer	0.000418	0.000857	CcSEcCtD
Icosapent ethyl—Pruritus—Docetaxel—stomach cancer	0.000417	0.000854	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—stomach cancer	0.000414	0.000849	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—stomach cancer	0.000414	0.000849	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—stomach cancer	0.000414	0.000849	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—stomach cancer	0.00041	0.000841	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—stomach cancer	0.000409	0.000839	CcSEcCtD
Icosapent ethyl—Asthenia—Capecitabine—stomach cancer	0.000409	0.000839	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	0.000408	0.00114	CbGpPWpGaD
Icosapent ethyl—Malaise—Doxorubicin—stomach cancer	0.000406	0.000832	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—stomach cancer	0.000405	0.000831	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—stomach cancer	0.000405	0.000829	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—stomach cancer	0.000405	0.000829	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—stomach cancer	0.000404	0.000828	CcSEcCtD
Icosapent ethyl—Pruritus—Capecitabine—stomach cancer	0.000403	0.000827	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—stomach cancer	0.000397	0.000814	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—stomach cancer	0.000397	0.000814	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—stomach cancer	0.000396	0.000811	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—stomach cancer	0.000395	0.000809	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—stomach cancer	0.000393	0.000806	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—stomach cancer	0.000391	0.000801	CcSEcCtD
Icosapent ethyl—Dizziness—Docetaxel—stomach cancer	0.00039	0.000798	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—stomach cancer	0.000389	0.000797	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—stomach cancer	0.000388	0.000795	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000387	0.000793	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—stomach cancer	0.000384	0.000787	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—stomach cancer	0.000384	0.000787	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—stomach cancer	0.000383	0.000786	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—stomach cancer	0.000383	0.000786	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—stomach cancer	0.000383	0.000786	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—stomach cancer	0.000379	0.000777	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—stomach cancer	0.000379	0.000776	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—stomach cancer	0.000378	0.000776	CcSEcCtD
Icosapent ethyl—Dizziness—Capecitabine—stomach cancer	0.000377	0.000773	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PPARG—stomach cancer	0.000375	0.00105	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Doxorubicin—stomach cancer	0.000375	0.000769	CcSEcCtD
Icosapent ethyl—Vomiting—Docetaxel—stomach cancer	0.000375	0.000768	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—stomach cancer	0.000374	0.000766	CcSEcCtD
Icosapent ethyl—Rash—Docetaxel—stomach cancer	0.000371	0.000761	CcSEcCtD
Icosapent ethyl—Dermatitis—Docetaxel—stomach cancer	0.000371	0.00076	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—stomach cancer	0.000369	0.000756	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—stomach cancer	0.000368	0.000753	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—stomach cancer	0.000368	0.000753	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000367	0.000751	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—stomach cancer	0.000365	0.000748	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—stomach cancer	0.000363	0.000744	CcSEcCtD
Icosapent ethyl—Vomiting—Capecitabine—stomach cancer	0.000363	0.000743	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000362	0.000742	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—stomach cancer	0.000362	0.000741	CcSEcCtD
Icosapent ethyl—Rash—Capecitabine—stomach cancer	0.00036	0.000737	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—stomach cancer	0.000359	0.000736	CcSEcCtD
Icosapent ethyl—Dermatitis—Capecitabine—stomach cancer	0.000359	0.000736	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—stomach cancer	0.000359	0.000735	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—stomach cancer	0.000355	0.000728	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—stomach cancer	0.000354	0.000726	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—stomach cancer	0.00035	0.000718	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—stomach cancer	0.00035	0.000717	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—stomach cancer	0.00035	0.000717	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—stomach cancer	0.000345	0.000708	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000343	0.000703	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—stomach cancer	0.00034	0.000696	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—stomach cancer	0.00034	0.000696	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALB—stomach cancer	0.000337	0.00094	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Methotrexate—stomach cancer	0.000336	0.000688	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000335	0.000686	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—stomach cancer	0.000332	0.000681	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—stomach cancer	0.000328	0.000672	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—stomach cancer	0.000327	0.000671	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—stomach cancer	0.000324	0.000663	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—NOS3—stomach cancer	0.000323	0.000899	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Doxorubicin—stomach cancer	0.00032	0.000655	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000317	0.00065	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—stomach cancer	0.000314	0.000644	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—stomach cancer	0.000314	0.000644	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—stomach cancer	0.000314	0.000644	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—stomach cancer	0.000305	0.000624	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—stomach cancer	0.000303	0.000621	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—stomach cancer	0.0003	0.000616	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—stomach cancer	0.000295	0.000822	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Doxorubicin—stomach cancer	0.000291	0.000596	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—stomach cancer	0.000285	0.000584	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—stomach cancer	0.000281	0.000576	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—stomach cancer	0.000281	0.000575	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—stomach cancer	0.00027	0.000553	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—stomach cancer	0.000268	0.000549	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—stomach cancer	0.000267	0.000548	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—stomach cancer	0.000264	0.000541	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—stomach cancer	0.000263	0.000538	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—stomach cancer	0.00026	0.000533	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—stomach cancer	0.000253	0.000518	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—stomach cancer	0.000251	0.000513	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—stomach cancer	0.00025	0.000513	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—stomach cancer	0.000243	0.000498	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—stomach cancer	0.000234	0.000479	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—stomach cancer	0.000232	0.000475	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—stomach cancer	0.000232	0.000475	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—stomach cancer	0.000182	0.000506	CbGpPWpGaD
